Skip to main content
Clinical Trials/IRCT20190519043632N1
IRCT20190519043632N1
Recruiting
Phase 3

Evaluation of Safety and efficacy of hydrogen peroxide 35% topical solution, in Comparision with cryotherapy in on treatment of patients with senile lentigo

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
33
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • People with Fitzpatrick skin type 1\-4
  • People without a history of drug allergy
  • Age over 16 years
  • No pregnancy or lactation
  • Failure to receive other treatments to eliminate lentigo in the last 6 weeks (such as cryotherapy or imiquimod ointment)
  • No Vitiligo

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials